カテゴリー： QYResearch, 世界

世界の耐性緑膿菌感染症薬市場 2019年

【英語タイトル】Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14315）・商品コード：DATA909X14315
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、耐性緑膿菌感染症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、半合成ペニシリン、セファロスポリン、ラクタム薬、その他に、用途別には、病院、診療所、在宅ケアにセグメント区分し、耐性緑膿菌感染症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・耐性緑膿菌感染症薬の世界市場概要
・耐性緑膿菌感染症薬の製造コスト構成分析
・耐性緑膿菌感染症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・耐性緑膿菌感染症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・耐性緑膿菌感染症薬のセグメント分析（種類別）
（半合成ペニシリン、セファロスポリン、ラクタム薬、その他）
・耐性緑膿菌感染症薬のセグメント分析（用途別）
（病院、診療所、在宅ケア）
・耐性緑膿菌感染症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（ContraFect Corp、Inhibrx LP、Achaogen Inc、LegoChem Biosciences Inc、Melinta Therapeutics Inc、Novartis AG、AmpliPhi Biosciences Corp、Biolytics Pharma、Shionogi & Co Ltd、）
・耐性緑膿菌感染症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Resistant Pseudomonas Aeruginosa Infections Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Resistant Pseudomonas Aeruginosa Infections Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Resistant Pseudomonas Aeruginosa Infections Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Resistant Pseudomonas Aeruginosa Infections Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Resistant Pseudomonas Aeruginosa Infections Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ContraFect Corp
Inhibrx LP
Achaogen Inc
LegoChem Biosciences Inc
Melinta Therapeutics Inc
Novartis AG
AmpliPhi Biosciences Corp
Biolytics Pharma
Shionogi & Co Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Semi-Synthetic Penicillin
Cephalosporin
Lactam Drugs
Others

Segment by Application
Hospital
Clinic
Home Care

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Resistant Pseudomonas Aeruginosa Infections Drugs
1.1 Definition of Resistant Pseudomonas Aeruginosa Infections Drugs
1.2 Resistant Pseudomonas Aeruginosa Infections Drugs Segment by Type
1.2.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Semi-Synthetic Penicillin
1.2.3 Cephalosporin
1.2.4 Lactam Drugs
1.2.5 Others
1.3 Resistant Pseudomonas Aeruginosa Infections Drugs Segment by Applications
1.3.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Resistant Pseudomonas Aeruginosa Infections Drugs Overall Market
1.4.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue (2014-2025)
1.4.2 Global Resistant Pseudomonas Aeruginosa Infections Drugs Production (2014-2025)
1.4.3 North America Resistant Pseudomonas Aeruginosa Infections Drugs Status and Prospect (2014-2025)
1.4.4 Europe Resistant Pseudomonas Aeruginosa Infections Drugs Status and Prospect (2014-2025)
1.4.5 China Resistant Pseudomonas Aeruginosa Infections Drugs Status and Prospect (2014-2025)
1.4.6 Japan Resistant Pseudomonas Aeruginosa Infections Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Status and Prospect (2014-2025)
1.4.8 India Resistant Pseudomonas Aeruginosa Infections Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Resistant Pseudomonas Aeruginosa Infections Drugs
2.3 Manufacturing Process Analysis of Resistant Pseudomonas Aeruginosa Infections Drugs
2.4 Industry Chain Structure of Resistant Pseudomonas Aeruginosa Infections Drugs

3 Development and Manufacturing Plants Analysis of Resistant Pseudomonas Aeruginosa Infections Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Resistant Pseudomonas Aeruginosa Infections Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Resistant Pseudomonas Aeruginosa Infections Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Resistant Pseudomonas Aeruginosa Infections Drugs Production and Capacity Analysis
4.2 Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Analysis
4.3 Resistant Pseudomonas Aeruginosa Infections Drugs Price Analysis
4.4 Market Concentration Degree

5 Resistant Pseudomonas Aeruginosa Infections Drugs Regional Market Analysis
5.1 Resistant Pseudomonas Aeruginosa Infections Drugs Production by Regions
5.1.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Production by Regions
5.1.2 Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue by Regions
5.2 Resistant Pseudomonas Aeruginosa Infections Drugs Consumption by Regions
5.3 North America Resistant Pseudomonas Aeruginosa Infections Drugs Market Analysis
5.3.1 North America Resistant Pseudomonas Aeruginosa Infections Drugs Production
5.3.2 North America Resistant Pseudomonas Aeruginosa Infections Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Resistant Pseudomonas Aeruginosa Infections Drugs Import and Export
5.4 Europe Resistant Pseudomonas Aeruginosa Infections Drugs Market Analysis
5.4.1 Europe Resistant Pseudomonas Aeruginosa Infections Drugs Production
5.4.2 Europe Resistant Pseudomonas Aeruginosa Infections Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Resistant Pseudomonas Aeruginosa Infections Drugs Import and Export
5.5 China Resistant Pseudomonas Aeruginosa Infections Drugs Market Analysis
5.5.1 China Resistant Pseudomonas Aeruginosa Infections Drugs Production
5.5.2 China Resistant Pseudomonas Aeruginosa Infections Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Resistant Pseudomonas Aeruginosa Infections Drugs Import and Export
5.6 Japan Resistant Pseudomonas Aeruginosa Infections Drugs Market Analysis
5.6.1 Japan Resistant Pseudomonas Aeruginosa Infections Drugs Production
5.6.2 Japan Resistant Pseudomonas Aeruginosa Infections Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Resistant Pseudomonas Aeruginosa Infections Drugs Import and Export
5.7 Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Market Analysis
5.7.1 Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Production
5.7.2 Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Import and Export
5.8 India Resistant Pseudomonas Aeruginosa Infections Drugs Market Analysis
5.8.1 India Resistant Pseudomonas Aeruginosa Infections Drugs Production
5.8.2 India Resistant Pseudomonas Aeruginosa Infections Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Resistant Pseudomonas Aeruginosa Infections Drugs Import and Export

6 Resistant Pseudomonas Aeruginosa Infections Drugs Segment Market Analysis (by Type)
6.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Production by Type
6.2 Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue by Type
6.3 Resistant Pseudomonas Aeruginosa Infections Drugs Price by Type

7 Resistant Pseudomonas Aeruginosa Infections Drugs Segment Market Analysis (by Application)
7.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption by Application
7.2 Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption Market Share by Application (2014-2019)

8 Resistant Pseudomonas Aeruginosa Infections Drugs Major Manufacturers Analysis
8.1 ContraFect Corp
8.1.1 ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.1.2 ContraFect Corp Product Introduction, Application and Specification
8.1.3 ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Inhibrx LP
8.2.1 Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.2.2 Inhibrx LP Product Introduction, Application and Specification
8.2.3 Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Achaogen Inc
8.3.1 Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.3.2 Achaogen Inc Product Introduction, Application and Specification
8.3.3 Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 LegoChem Biosciences Inc
8.4.1 LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.4.2 LegoChem Biosciences Inc Product Introduction, Application and Specification
8.4.3 LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Melinta Therapeutics Inc
8.5.1 Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.5.2 Melinta Therapeutics Inc Product Introduction, Application and Specification
8.5.3 Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Novartis AG
8.6.1 Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.6.2 Novartis AG Product Introduction, Application and Specification
8.6.3 Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 AmpliPhi Biosciences Corp
8.7.1 AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.7.2 AmpliPhi Biosciences Corp Product Introduction, Application and Specification
8.7.3 AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biolytics Pharma
8.8.1 Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.8.2 Biolytics Pharma Product Introduction, Application and Specification
8.8.3 Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Shionogi & Co Ltd
8.9.1 Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
8.9.2 Shionogi & Co Ltd Product Introduction, Application and Specification
8.9.3 Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Resistant Pseudomonas Aeruginosa Infections Drugs Market
9.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Trend Analysis
9.1.1 Global Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Resistant Pseudomonas Aeruginosa Infections Drugs Regional Market Trend
9.2.1 North America Resistant Pseudomonas Aeruginosa Infections Drugs Forecast 2019-2025
9.2.2 Europe Resistant Pseudomonas Aeruginosa Infections Drugs Forecast 2019-2025
9.2.3 China Resistant Pseudomonas Aeruginosa Infections Drugs Forecast 2019-2025
9.2.4 Japan Resistant Pseudomonas Aeruginosa Infections Drugs Forecast 2019-2025
9.2.5 Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Forecast 2019-2025
9.2.6 India Resistant Pseudomonas Aeruginosa Infections Drugs Forecast 2019-2025
9.3 Resistant Pseudomonas Aeruginosa Infections Drugs Market Trend (Product Type)
9.4 Resistant Pseudomonas Aeruginosa Infections Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Resistant Pseudomonas Aeruginosa Infections Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Resistant Pseudomonas Aeruginosa Infections Drugs
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share by Types in 2018
Figure Semi-Synthetic Penicillin Product Picture
Figure Cephalosporin Product Picture
Figure Lactam Drugs Product Picture
Figure Others Product Picture
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Home Care
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue (Million USD) (2014-2025)
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs) (2014-2025)
Figure North America Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Million USD) (2014-2025)
Figure Europe Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Million USD) (2014-2025)
Figure China Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Million USD) (2014-2025)
Figure Japan Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Million USD) (2014-2025)
Figure India Resistant Pseudomonas Aeruginosa Infections Drugs Market Size (Million USD) (2014-2025)
Table Resistant Pseudomonas Aeruginosa Infections Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Resistant Pseudomonas Aeruginosa Infections Drugs in 2018
Figure Manufacturing Process Analysis of Resistant Pseudomonas Aeruginosa Infections Drugs
Figure Industry Chain Structure of Resistant Pseudomonas Aeruginosa Infections Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Manufacturing Plants Distribution
Table Resistant Pseudomonas Aeruginosa Infections Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Resistant Pseudomonas Aeruginosa Infections Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Resistant Pseudomonas Aeruginosa Infections Drugs Production Share by Manufacturers in 2018
Table Resistant Pseudomonas Aeruginosa Infections Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Share by Manufacturers in 2018
Table Resistant Pseudomonas Aeruginosa Infections Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share by Regions 2014-2019
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share by Regions in 2018
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share by Regions 2014-2019
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share by Regions in 2018
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Resistant Pseudomonas Aeruginosa Infections Drugs Consumption Market Share by Regions 2014-2019
Figure North America Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Resistant Pseudomonas Aeruginosa Infections Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Resistant Pseudomonas Aeruginosa Infections Drugs Production, Consumption Import and Export (K Pcs)
Figure China Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Resistant Pseudomonas Aeruginosa Infections Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Resistant Pseudomonas Aeruginosa Infections Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Production, Consumption Import and Export (K Pcs)
Figure India Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Resistant Pseudomonas Aeruginosa Infections Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Resistant Pseudomonas Aeruginosa Infections Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Resistant Pseudomonas Aeruginosa Infections Drugs Market Share by Application (2014-2019)
Table ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table ContraFect Corp Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table Inhibrx LP Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table Achaogen Inc Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table LegoChem Biosciences Inc Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table Melinta Therapeutics Inc Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table Novartis AG Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table AmpliPhi Biosciences Corp Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table Biolytics Pharma Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Table Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Production Sites and Area Served
Table Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Product Introduction, Application and Specification
Table Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate (2014-2019)
Table Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Production Market Share (2014-2019)
Figure Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Market Share (2014-2019)
Table Shionogi & Co Ltd Resistant Pseudomonas Aeruginosa Infections Drugs Main Business and Markets Served
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Resistant Pseudomonas Aeruginosa Infections Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Resistant Pseudomonas Aeruginosa Infections Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Resistant Pseudomonas Aeruginosa Infections Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Resistant Pseudomonas Aeruginosa Infections Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Resistant Pseudomonas Aeruginosa Infections Drugs by Application (2019-2025)
Table Resistant Pseudomonas Aeruginosa Infections Drugs Distributors List
Table Resistant Pseudomonas Aeruginosa Infections Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

ContraFect Corp、Inhibrx LP、Achaogen Inc、LegoChem Biosciences Inc、Melinta Therapeutics Inc、Novartis AG、AmpliPhi Biosciences Corp、Biolytics Pharma、Shionogi & Co Ltd、

★調査レポート[世界の耐性緑膿菌感染症薬市場 2019年] (コード：DATA909X14315)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の耐性緑膿菌感染症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の緑膿菌肺炎治療薬市場 2019年
    DATA909X13859 / QYResearch / 2019年11月20日 / ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・緑膿菌肺炎治療薬の世界市場概要 ・緑膿菌肺炎治療薬の製造コスト構成分析 ・緑膿菌肺炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・緑膿菌肺炎治療薬のセグメント分析（種類別） （アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）...The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 緑膿菌感染症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18876 / QYResearch / 2019年11月25日 / ※当調査レポートでは、緑膿菌感染症治療の世界市場について調査・分析し、緑膿菌感染症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（鼻、経口、静脈内）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の緑膿菌感染症治療市場動向 ・主要企業別マーケットシェア ・緑膿菌感染症治療の種類別市場規模2014-2019 （鼻、経口、静脈内） ・緑膿菌感染症治療の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・緑膿菌感染症治療の北米市場：主要企業・種類別/用途別市場規模 ・緑膿菌感染症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...In 2018, the global Pseudomonas Aeruginosa Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Pseudomonas Aeruginosa Infection Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pseudomonas Aeruginosa Infection Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Allergan Teva Pharmaceutical Industries Pfizer Lupin Pharmaceuticals AstraZeneca Merck Bristol-Myers Squibb Janssen...
  • 世界のバンコマイシン耐性腸球菌フェシウム用薬剤市場 2019年
    DATA909X06815 / QYResearch / 2019年11月15日 / ※本調査レポートは、バンコマイシン耐性腸球菌フェシウム用薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ダプトマイシン、リネゾリド、キヌプリスチン/ダルフォプリスチン、アンピシリン、クロラムフェニコール、その他に、用途別には、病院、診療所、その他にセグメント区分し、バンコマイシン耐性腸球菌フェシウム用薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・バンコマイシン耐性腸球菌フェシウム用薬剤の世界市場概要 ・バンコマイシン耐性腸球菌フェシウム用薬剤の製造コスト構成分析 ・バンコマイシン耐性腸球菌フェシウム用薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・バンコマイシン耐性腸球菌フェシウム用薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・バンコマイシン耐性腸球菌フェシウム用薬剤のセグメント分析（種類別） （ダプトマイシン、リネゾリド、キヌプリスチン/ダルフォプリスチン、アンピシリン、クロラムフェニコール、その他）...The global Drugs for Vancomycin-Resistant Enterococcus Faecium market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Drugs for Vancomycin-Resistant Enterococcus Faecium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Vancomycin-Resistant Enterococcus Faecium market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Drugs for Vancomycin-Resistant Enterococcus Faecium in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の人工関節感染症治療市場 2019年
    DATA909X13818 / QYResearch / 2019年11月20日 / ※本調査レポートは、人工関節感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他に、用途別には、病院、診療所、その他にセグメント区分し、人工関節感染症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・人工関節感染症治療の世界市場概要 ・人工関節感染症治療の製造コスト構成分析 ・人工関節感染症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・人工関節感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・人工関節感染症治療のセグメント分析（種類別） （フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）...The global Prosthetic Joint Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prosthetic Joint Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prosthetic Joint Infections Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Prosthetic Joint Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のライノウイルス感染薬市場 2019年
    DATA909X14407 / QYResearch / 2019年11月20日 / ※本調査レポートは、ライノウイルス感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ライノウイルス感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ライノウイルス感染薬の世界市場概要 ・ライノウイルス感染薬の製造コスト構成分析 ・ライノウイルス感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ライノウイルス感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ライノウイルス感染薬のセグメント分析（種類別） （塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）...The global Rhinovirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhinovirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhinovirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rhinovirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のロタウイルス感染症治療薬市場 2019年
    DATA909X14590 / QYResearch / 2019年11月20日 / ※本調査レポートは、ロタウイルス感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、農業、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ロタウイルス感染症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ロタウイルス感染症治療薬の世界市場概要 ・ロタウイルス感染症治療薬の製造コスト構成分析 ・ロタウイルス感染症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ロタウイルス感染症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ロタウイルス感染症治療薬のセグメント分析（種類別） （農業、その他）...The global Rotavirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rotavirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rotavirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の淋菌感染症治療市場 2019年
    DATA909X11919 / QYResearch / 2019年11月20日 / ※本調査レポートは、淋菌感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、淋菌感染症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・淋菌感染症治療の世界市場概要 ・淋菌感染症治療の製造コスト構成分析 ・淋菌感染症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・淋菌感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・淋菌感染症治療のセグメント分析（種類別） （クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）...The global Neisseria Gonorrhoeae Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria Gonorrhoeae Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria Gonorrhoeae Infections Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria Gonorrhoeae Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の髄膜炎菌感染症治療薬市場 2019年
    DATA909X11920 / QYResearch / 2019年11月20日 / ※本調査レポートは、髄膜炎菌感染症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、MGBBP-3、NCL-195、TP-10、その他に、用途別には、病院、クリニック、その他にセグメント区分し、髄膜炎菌感染症治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・髄膜炎菌感染症治療薬の世界市場概要 ・髄膜炎菌感染症治療薬の製造コスト構成分析 ・髄膜炎菌感染症治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・髄膜炎菌感染症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・髄膜炎菌感染症治療薬のセグメント分析（種類別） （MGBBP-3、NCL-195、TP-10、その他）...The global Neisseria meningitidis Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria meningitidis Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria meningitidis Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria meningitidis Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆